Cambridge, Mass-based startup Wild Microbes has raised $3.3 million in a pre-seed round to help unlock the potential of precision fermentation through the use of a gene-editing approach it claims can create superior production hosts. Read more You might also be interested in News October 26, 2026“We’re In. We’ve Got You.” Freeflow’s Journey with Iambic Therapeutics News October 9, 2026Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom News June 3, 2026Freeflow Expands Into the UCSF Ecosystem